Antioxidative biomarkers and cancerogenesis

Jugoslovenska Medicinska Biohemija

Volumn 25, Issue 4, 2006, Pages 397-402

  Pajović, Snežana B ^a   Saičić, Zorica S ^a   Pejić, Snežana ^a   Kasapović, Jelena ^a   Stojiljković, Vesna ^a   Kanazir, Dušan T ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antioxidant enzymes; Biomarkers; Cancer

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID HYDROPEROXIDE; SUPEROXIDE DISMUTASE;

BLOOD SAMPLING; CARCINOGENESIS; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; UTERUS MYOMA;

EID: 33845358729     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMB0604397P     Document Type: Conference Paper

References (43)

1. Pajović S, Pejić S, Kasapović J, Radojčić M, Borojević N, Radošević- Jelić Lj . Role of superoxide dismutase in individualization of breast cancer radiation therapy protocols. Arch Oncol 2003; 11: 191-2.
2. Kanazir DT, Pajović SB, Radojčić MB. Molecular mechanism of stress-induced cardiovascular disease. Serbian Academy of Sciences and Art: Monographs Vol. DCLV, 2004: 1-94.
3. Pajović SB, Kasapović J, Pejić S, Stanković J, Borojević N, Radošević-Jelić Lj. Superoxide dismutase profile in circulation of breast cancer patients as a predictive assay in radiotherapy. Iugosl Physiol Pharmacol Acta 2004; 40: 151-8.
4. Breimer LH. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinogenesis 1990; 3: 188-97.
5. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994; 54: 1890s-4s.
6. Floyd RA. 8-Hydroxy-2′-deoxyguanosine in carcinogenesis. Carcinogenesis 1990; 11: 1447-50.
7. Rice-Evans C, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 1993; 32: 71-110.
8. White AA, Crawford KM, Patt CS, Lad PJ. Activation of soluble guanylate cylase from rat lung by incubation or by hydrogen peroxide. J Biol Chem 1976; 251: 7304-12.
9. 2+ sequestration by the plasma membrane fraction from rat liver. FEBS Lett 1983; 163: 136-9.
10. Kerr LD, Inoue J, Verm IM. Signal transduction: the nuclear target. Curr Opin Cell Biol 1992; 4: 496-501.
11. Davies KJA. Intracellular proteolytic systems may function as secondary antioxidants defenses: a hypothesis. J Free Radic Biol Medicine 1986; 9: 155-73.
12. Nelson RL. Dietary iron and colorectal cancer risk. Free Radic Biol Med 1992; 12: 161-8.
13. Briviba K, Sies H. Nonenzymatic antioxidant defense systems. In: FREI B (ed). Natural Antioxidants in Human Health and Diseases. San Diego, CA: Academic Press, 1994: 107-28.
14. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74: 139-62.
15. Pajović SB, Cavrić G, Kasapović J, Todorović A, Pejić S. Activities of superoxide dismutase and catalase in cancerous and non-cancerous human kidney tissues. J Med Sci 2002; 2: 234-6.
16. Mutter GL. Diagnosis of premalignant endometrial disease. J Clin Pathol 2002; 55: 326-31.
17. Longacre TA, Kempson RL, Hendrickson MR. Endometrial hyperplasia, metaplasia and carcinoma. In: FOX H, WELLS M (eds). Obstetrical and Gynaecological Pathology. New York: Churchhill Livingstone, 1995: 421-510.
18. Mutter GL. The Endometrial Collaborative Group. Endometrial Intraepithelial Neoplasia (EIN): Will it bring order to chaos? Gynecol Oncol 2000; 76: 287-90.
19. Baak JPA, Mutter GL. EIN and WHO94. J Clin Pathol 2005; 58:1-6.
20. Hammond R, Johnson J. Endometrial hyperplasia. Curr Obstet Gynaecol 2004; 14: 99-103.
21. Chiou JF, Hou ML. Elevated lipid peroxidation and disturbed antioxidant enzyme activities in plasma and erythrocytes of patients with uterine cervicitis and myoma. Clin Biochem 1999; 32: 189-92.
22. Manoharan S, Kolanjiappan K, Kayalvizni M. Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell Mol Biol Lett 2004; 9: 699-707.
23. Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta 2002; 326: 143-9.
24. Manoharan S, Kolanjiappan K, KayalvizniA M, Sethupathy S. Lipid peroxidation and antioxidant status in cervical cancer patients. J Biochem Mol Biol Biophys 2002; 6: 225-7.
25. Ahmed MI, Fayed ST, Hossein H, Tash FM. Lipid peroxidation and antioxidant status in human cervical carcinoma. Dis Markers 1999; 15: 283-91.
26. Hristozov D, Gadjeva V, Vlaykova T, Dimitrov G. Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem 2001; 109: 331-6.
27. Abiaka C, Al-Awadif, Al-Sayer H, Gulshan S, Behbehani A, Farghally M. Activities of erythrocyte antioxidant enzymes in cancer patients. J Clin Lab Anal 2002; 16: 167-71.
28. Manju V, Kalaivani-Sailaja J, Nalini N. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem 2002; 35: 621-5.
29. Bagchi K, Puri S. Free radicals and antioxidants in health and disease. East Mediterr Health J 1998; 4: 350-60.
30. Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L, Sulkowska M. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 2005; 11: 403-6.
31. Van Ginkel G, Sevanian A. Lipid peroxidation induced membrane structural alterations. Methods Enzymol 1994; 233: 273-88.
32. Toyokuni S. Oxidative stress and cancer: the role of redox regulation. Biotherapy 1998; 11: 147-54.
33. Bhuvaraharamurthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Mol Cell Biochem 1996; 158: 17-23.
34. Mila-Kierzenkowska C, Kedziora-Kornatowska K, Wozniak A, Drewa T, Wozniak B, Drewa S, et al. The effect of brachytherapy on antioxidant status and lipid peroxidation in patients with cancer of the uterine cervix. Cell Mol Biol Lett 2004; 9: 511-8.
35. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, Kirkman HN. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 1996; 87: 1595-9.
36. 2 -removing enzyme in human erythrocytes. Blood 1997; 90: 4973-8.
37. Nagababu AE, Chrest FJ, Rifkind JM. Hydrogen-peroxide-induced heme degradation in red blood cells: the protective roles of catalase and glutathione peroxidase. Biochim Biophys Acta 2003; 1620: 211-7.
38. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem 1982; 57: 1571-8.
39. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide dismutase radical. Arch Biochem Biophys 1985; 240: 500-8.
40. Richards RS, Roberts TK, Mcgregor NR, Dunstan RH, Butt HL. The role of erythrocytes in the inactivation of free radicals. Med Hypotheses 1998; 50: 363-7.
41. Prchal JSK, Srivastava SK, Beutler E. Active transport of GSSG from reconstituted erythrocyte ghosts. Blood 1975; 46: 111-7.
42. Thorn SR, Kang M, Fisher D, Ischiropoulos H. Release of glutathione from erythrocytes and other markers of oxidative stress in carbon monoxide poisoning. J Appl Physiol 1997; 82: 1424-32.
43. Sharma R, Awasthi S, Zimniak P, Awasthi YC. Transport of glutathione-conjugates in human erythrocytes. Acta Biochim Pol 2000; 47: 751-62.